Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2007 Oct 8;64(22):2985–2993. doi: 10.1007/s00018-007-7308-3

Arachidonic acid signaling is involved in the mechanism of imidazoline-induced KATP channel-independent stimulation of insulin secretion

V V Sharoyko 1, I I Zaitseva 1,2, B Leibiger 1, S Efendić 1, P-O Berggren 1, S V Zaitsev 1,2,
PMCID: PMC11136028  PMID: 17922229

Abstract.

The mechanism by which the novel, pure glucose-dependent insulinotropic, imidazoline derivative BL11282 promotes insulin secretion in pancreatic islets has been investigated. The roles of KATP channels, α2-adrenoreceptors, the I1-receptor-phosphatidylcholine-specific phospholipase (PC-PLC) pathway and arachidonic acid signaling in BL11282 potentiation of insulin secretion in pancreatic islets were studied. Using SUR1(-/-) deficient mice, the previous notion that the insulinotropic activity of BL11282 is not related to its interaction with KATP channels was confirmed. Insulinotropic activity of BL11282 was not related to its effect on α2-adrenoreceptors, I1-imidazoline receptors or PC-PLC. BL11282 significantly increased [3H]arachidonic acid production. This effect was abolished in the presence of the iPLA2 inhibitor, bromoenol lactone. The data suggest that potentiation of glucose-induced insulin release by BL11282, which is independent of concomitant changes in cytoplasmic free Ca2+ concentration, involves release of arachidonic acid by iPLA2 and its metabolism to epoxyeicosatrienoic acids through the cytochrome P-450 pathway.

Keywords. BL11282, imidazolines, insulin secretion, arachidonic acid, calcium-independent phospholipase A2, cytochrome P-450

Footnotes

Received 5 July 2007; received after revision 18 September 2007; accepted 20 September 2007


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES